Position in QGEN
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$300,820
-$1,852,073 QoQ
Shares Held
7,513
-84.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in QGEN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Qsemble Capital Management, LP holds $15,729,397 across 8 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
23,646 | $4,504,090 | |
| 2 | RVTY |
Revvity, Inc.
|
33,179 | $3,691,495 | |
| 3 | A |
Agilent Technologies, Inc.
|
23,610 | $3,136,116 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
2,460 | $1,233,345 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
5,909 | $1,141,736 | |
| 6 | WAT |
Waters Corp /De/
|
2,520 | $945,100 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
1,574 | $828,616 | |
| 8 | GH |
Guardant Health, Inc.
|
1,659 | $248,899 |
All Filings in QGEN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $300,820 | 7,513 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,152,893 | 47,874 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,355,825 | 75,108 | Shares | Sole | 2025-11-13 | |
| 2025-03-31 | $1,595,360 | 39,735 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,045,351 | 45,932 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $4,704,829 | 103,244 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $671,417 | 15,618 | Shares | Sole | 2024-05-07 | |
| 2023-09-30 | $2,106,503 | 50,400 | Shares | Sole | 2023-11-07 | |
| No filing history on record for this holder in this stock. | ||||||